Dietary carbohydrates and fatty liver disease: de novo lipog... : Current Opinion in Clinical
Nutrition & Metabolic Care Dietary carbohydrates and fatty liver disease: de novo lipogenesis …

The response gene to complement (RGC)-32 acts as a cell cycle regulator and mediator of
TGF-β effects. However, recent studies have revealed other functions for RGC-32 in diverse …

Objective—The objective of this study is to determine the role and underlying mechanisms of
RGC-32 (response gene to complement 32 protein) in atherogenesis. Approach and Results …

Some previous studies in tissue fibrosis have suggested a profibrotic contribution from
elevated expression of a protein termed either RGCC (regulator of cell cycle) or RGC-32 …

Diclofenac effectively reduces pain and inflammation; however, its use is associated with
hepato-and nephrotoxicity. To delineate mechanisms of injury, we investigated a clinically …

Systemic lupus erythematosus is an autoimmune disease that results in immune-mediated
damage to kidneys and other organs. We investigated the role of response gene to …

Obesity is an important independent risk factor for type 2 diabetes, cardiovascular diseases,
and many other chronic diseases. The objective of this study was to determine the role of …

Response gene to complement 32 (RGC32) is a protein that was identified in rat
oligodendrocytes after complement activation. It is expressed in most of the organs and …

Rationale: Hypertension prevalence is much higher among children and adolescents with
low birth weight and greater postnatal weight gain than in individuals with normal birth …

Response gene to complement 32 (RGC32) is a transcription factor that regulates the
expression of multiple genes involved in cell growth, viability and tissue-specific …